Learning Objectives:
- After attending this presentation, learners will be able to:
- Interpret updated data on HIV transmission risk, including low-level viremia
- Evaluate innovative HIV testing strategies to improve diagnosis and linkage to care
- Compare oral and long-acting PrEP strategies, including real-world effectiveness
- Identify barriers to PrEP uptake, persistence, and equitable access
- Assess implementation challenges limiting the impact of HIV prevention strategies
- Evaluate emerging prevention approaches, including long-acting and novel agents
- Summarize evidence for doxycycline post-exposure prophylaxis (doxy-PEP)
- Balance benefits and risks of doxy-PEP, including antimicrobial resistance
- Assess emerging PEP strategies and their role in prevention
- Integrate HIV and STI prevention strategies into patient-centered care
Featured Speaker:
William Mazur, MD- Medical Director, Holloway Community Program
CEUs
1 CME will be offered for attending this event live. This activity was planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of Delaware and the MAAETC. Continuing Education credits issued for participation in CE activity may not apply toward license renewal in all states. It is the responsibility of each participant to verify the requirements of their state licensing board(s).
